Zacks Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-15,569
| Closed | -$1.12M | – | 724 |
|
|
2023
Q4 | $1.12M | Buy |
15,569
+235
| +2% | +$16.8K | 0.01% | 366 |
|
|
2023
Q3 | $799K | Buy |
15,334
+5,237
| +52% | +$273K | 0.01% | 402 |
|
|
2023
Q2 | $639K | Buy |
10,097
+106
| +1% | +$6.71K | 0.01% | 428 |
|
|
2023
Q1 | $541K | Buy |
9,991
+1,128
| +13% | +$61.1K | 0.01% | 440 |
|
|
2022
Q4 | $469K | Buy |
8,863
+377
| +4% | +$20K | 0.01% | 445 |
|
|
2022
Q3 | $395K | Buy |
8,486
+1,302
| +18% | +$60.6K | 0.01% | 449 |
|
|
2022
Q2 | $410K | Buy |
+7,184
| New | +$410K | 0.01% | 455 |
|